Houlihan Lokey Advises Magnetrol International

Houlihan Lokey is pleased to announce that Magnetrol International, Inc. (Magnetrol) has been acquired by AMETEK, Inc. (NYSE:AME). Magnetrol will be integrated into the Sensors, Test & Calibration Business Unit within the Electronic Instruments Group of AMETEK. The transaction closed on March 26, 2021.

Magnetrol was founded in 1932 and is headquartered in Aurora, Illinois. Magnetrol is a global leader in the design, development, and manufacturing of highly engineered, mission-critical level and flow control products. Magnetrol’s products include indicators, sensors, transmitters, and switches, which are critical in safety, process optimization, and yield across multiple industries, including oil and gas, power, chemicals, water, medical devices, and pharmaceuticals. Through its global distributor network of over 150 channel partners, Magnetrol sells its process instrumentation to geographically diverse end users across multiple industries. Magnetrol has a global footprint of seven manufacturing and assembly facilities serving customers in over 100 different countries.

AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with annual sales of approximately $5 billion. AMETEK has 17,000 employees at more than 150 operating locations and a global network of sales, service, and support locations in 30 countries around the world. AMETEK consists of two operating groups, with both having highly differentiated technology and leading positions in niche markets. The Electronic Instruments Group, into which Magnetrol will be integrated, is a worldwide leader in the design and manufacture of advanced analytical, test, and measurement instrumentation for the energy, aerospace, power, research, medical, and industrial markets.

The integration of Magnetrol into the Sensors, Test & Calibration Business Unit is highly complementary, leveraging current AMETEK RF capacitive measurement technology and Magnetrol’s diverse products and applications. The combined business unit will operate 12 manufacturing facilities globally, in addition to its various sales and service centers.

Houlihan Lokey served as the exclusive sellside financial advisor to Magnetrol and assisted in initiating, structuring, and negotiating the transaction on Magnetrol’s behalf. The transaction exemplifies the continued success of Houlihan Lokey’s dedicated coverage of the industrial technology sector.